| Period Ending | Jun 29, 2012 | Jun 29, 2011 |
|---|
|
Total Revenue
|
4,308
|
1,141
| | Cost of Revenue |
-
|
-
| | |
Gross Profit
|
4,308
|
1,141
| |
|
Operating Expenses |
|
Research Development | 14,864 | 10,204 |
|
Selling General and Administrative | 7,971 | 5,996 |
|
Non Recurring |
-
| 594 |
|
Others | 387 | 69 |
|
|
|
Total Operating Expenses |
-
| 16,864 | | | |
Operating Income or Loss
|
(18,914)
|
(15,722)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,526) |
-
|
|
Earnings Before Interest And Taxes | (20,441) | (15,722) |
|
Interest Expense |
-
| 6,847 |
|
Income Before Tax | (20,441) | (22,570) |
|
Income Tax Expense |
-
|
-
|
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (20,441) | (22,570) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | | |
Net Income
|
(20,441)
|
(22,570)
| | Preferred Stock And Other Adjustments |
-
|
-
| | |
Net Income Applicable To Common Shares
|
(20,441)
|
(22,570)
|
|
0.43(15.47%) May 17, 3:58PM EDT